Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Regul Pept ; 115(3): 195-201, 2003 Oct 15.
Article in English | MEDLINE | ID: mdl-14556961

ABSTRACT

Recently, our group described a B1-mediated stimulatory effect of des-Arg(9)-bradykinin (DABK) on the Na(+)-ATPase activity of proximal tubule basolateral membranes (BLM) [Biochim. Biophys. Acta 1431 (1999) 483.]. Data in the present report suggest the participation of a phosphatidylinositol-specific PLC (PI-PLC)/protein kinase C (PKC) pathway as the molecular mechanism of DABK-mediated stimulation of the Na(+)-ATPase activity since (i) 10(-8) M DABK activates PI-PLC activity; (ii) 10(-9) M U73122, a PI-PLC inhibitor, abolishes the effect of 10(-8) M DABK on the Na(+)-ATPase activity; (iii) 10(-8) M DABK increases phosphoprotein formation by 34%. This effect is completely reversed by 10(-7) M calphostin C, an inhibitor of PKC; (iv) 20 ng/ml TPA, an activator of PKC, and 10(-8) M DABK stimulate the Na(+)-ATPase activity in a similar and nonadditive manner. Furthermore, the effect of 10(-8) M DABK is completely reversed by calphostin C; (v) 10(-8) M DABK increases phosphoserine residue levels by 54%. This effect is completely reversed by 10(-7) M calphostin C.


Subject(s)
Adenosine Triphosphatases/metabolism , Cation Transport Proteins/metabolism , Kidney Tubules, Proximal/enzymology , Protein Kinase C/metabolism , Receptor, Bradykinin B1/physiology , Animals , Bradykinin/analogs & derivatives , Bradykinin/antagonists & inhibitors , Bradykinin/pharmacology , Enzyme Inhibitors/pharmacology , Naphthalenes/pharmacology , Phosphatidylinositols/metabolism , Phosphorylation , Phosphoserine/metabolism , Protein Kinase C/antagonists & inhibitors , Swine
2.
Biochim Biophys Acta ; 1512(1): 90-7, 2001 May 02.
Article in English | MEDLINE | ID: mdl-11334627

ABSTRACT

This study describes the modulation of the ouabain-insensitive Na(+)-ATPase activity from renal proximal tubule basolateral membranes (BLM) by protein kinase C (PKC). Two PKC isoforms were identified in BLM, one of 75 kDa and the other of 135 kDa. The former correlates with the PKC isoforms described in the literature but the latter seems to be a novel isoform, not yet identified. Both PKC isoforms of BLM are functional since a protein kinase C activator, TPA, increased the total hydroxylamine-resistant 32P(i) incorporation from [gamma-32P]ATP into the BLM. In parallel, TPA stimulated the Na(+)-ATPase activity from BLM in a dose-dependent manner, the effect being reversed by the PKC inhibitor sphingosine. The stimulatory effect of TPA on Na(+)-ATPase involved an increase in the V(max) (from 13.4+/-0.6 nmol P(i) mg(-1) min(-1) to 25.2+/-1.4 nmol P(i) mg(-1) min(-1), in the presence of TPA, P<0.05) but did not change the apparent affinity for Na(+) (K(0.5)=14.5+/-2.1 mM in control and 10.0+/-2.1 mM in the presence of TPA, P>0.07). PKC involvement was further confirmed by stimulation of the Na(+)-ATPase activity by the catalytic subunit of PKC (PKC-M). Finally, the phosphorylation of an approx. 100 kDa protein in the BLM (the suggested molecular mass of Na(+)-ATPase [1]) was induced by TPA. Taken together, these findings indicate that PKCs resident in BLM stimulate Na(+)-ATPase activity which could represent an important mechanism of regulation of proximal tubule Na(+) reabsorption.


Subject(s)
Adenosine Triphosphatases/metabolism , Cation Transport Proteins , Kidney Tubules, Proximal/metabolism , Protein Kinase C/metabolism , Animals , Cell Fractionation , Cell Membrane/metabolism , Electrophoresis, Polyacrylamide Gel , Isoenzymes/analysis , Kidney Tubules, Proximal/enzymology , Kinetics , Phosphorylation , Protein Kinase C/analysis , Signal Transduction , Sodium/metabolism , Swine
3.
Acta Trop ; 73(2): 93-108, 1999 Jul 30.
Article in English | MEDLINE | ID: mdl-10465050

ABSTRACT

The role of phospholipids (PLs) in the signal transduction pathways that are activated by a mitogenic stimulus (foetal calf serum) in Trypanosoma cruzi epimastigotes (EPI) was investigated. Only phosphatidylinositol-bis-phosphate was significantly altered in this process. Other phosphoinositides, including major PLs such as phosphatidylcholine and phosphatidylethanolamine, were unaltered. Lysophosphatidic acid, reported to be the primary active substance in effects of serum in other systems, had no mitogenic activity when added to epimastigote cultures. Involvement of phosphoinositide-specific phospholipase C was established using the inhibitors ET-18-OCH3 and U73122, which prevented phosphatidylinositol-bis-phosphate hydrolysis; the latter compound decreased T. cruz proliferation. The intracellular signalling downstream to the phospholipase C was mediated by Ca2+/PL-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase II, judging from the marked decrease in replication caused by the specific inhibitors staurosporine, derythro-sphingosine and KN-93. Previous reports have demonstrated a dual control of cell growth in EPI, whose proliferation is stimulated by the activation of a phospholipase C system and inhibited by activation of an adenylate cyclase system. Investigating this 'cross-talk' phenomenon, we observed that an increase in intracellular cAMP inhibited growth mediated by a cAMP-dependent protein kinase, but did not cause PL alterations, and also did not prevent the effect of serum on them.


Subject(s)
Carbazoles , Phospholipids/metabolism , Trypanosoma cruzi/physiology , Adenylate Cyclase Toxin , Animals , Benzylamines/pharmacology , Cell Division , Culture Media/pharmacology , Cyclic AMP/metabolism , Dose-Response Relationship, Drug , Estrenes , Indoles/pharmacology , Lysophospholipids/pharmacology , Phosphatidylcholines/analysis , Phosphatidylethanolamines/analysis , Phosphatidylinositols/analysis , Protein Kinases/metabolism , Pyrroles/pharmacology , Pyrrolidinones , Signal Transduction , Sphingosine/analogs & derivatives , Staurosporine/pharmacology , Sulfonamides/pharmacology , Trypanosoma cruzi/cytology , Type C Phospholipases/antagonists & inhibitors , Type C Phospholipases/metabolism , Virulence Factors, Bordetella/pharmacology
4.
Parasitol Res ; 85(3): 232-8, 1999 Mar.
Article in English | MEDLINE | ID: mdl-9951967

ABSTRACT

Inositol has been cited as being essential for the growth of micro-organisms and animals. Its action rests mostly in the formation of a set of inositol-containing lipids, including phosphatidylinositol and its phosphorylated derivatives. To evaluate the functional responses coupled to the phosphoinositide metabolism in Trypanosoma cruzi we used myo-inositol and its six fluorinated analogues. Their uptake into epimastigotes was characterised using tritium-labeled myo-inositol and monodeoxyfluoro-myo-inositols. The analogues were tested for their ability to inhibit [3H]-myo-inositol incorporation into phosphoinositides and the proliferation of epimastigotes and amastigotes. The results showed differences between T. cruzi and mammalian systems in the responses to the fluorinated analogues. We found that the 3-, 5- and 6-fluoro analogues did not enter the cells but had an inhibitory effect on the incorporation of the radioactive inositol into lipids and on the amastigotes' and epimastigotes' replication. The most effective inhibitor, 1-D-6-deoxy-6-myo-inositol, had no effect on mammalian cell division.


Subject(s)
Inositol/analogs & derivatives , Inositol/pharmacokinetics , Phosphatidylinositols/metabolism , Trypanosoma cruzi/growth & development , Animals , Autoradiography , Cell Division/drug effects , Fluorine , Inositol/metabolism , Reproduction/drug effects , Tritium , Trypanosoma cruzi/cytology , Trypanosoma cruzi/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...